Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-036035
Filing Date
2009-07-08
Accepted
2009-07-08 17:00:21
Documents
1
Period of Report
2009-07-06

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c87739_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c87739_4x0.xml 4 11181
  Complete submission text file 0001209191-09-036035.txt   13325
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT ST, SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address
Maimon Yossi (Reporting) CIK: 0001385115 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 09935484